Biocon Biologics And Civica Bring Lower-Cost Insulin Glargine To U.S. Patients – LAmag
A new agreement between Biocon Biologics Ltd. and nonprofit generic drug maker Civica, Inc. is set to expand access to affordable insulin for millions of Americans living with…
Read more Biocon Biologics And Civica Bring Lower-Cost Insulin Glargine To U.S. Patients – LAmag